← Back to Search

Acupuncture for Peripheral Neuropathy

N/A

Waitlist Available

Led By Ting Bao, MD, DABMA, MS

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Solid tumor survivors with no evidence of disease

Moderate to severe CIPN, defined by symptoms such as numbness, tingling, or pain ratings of 4 or greater on a 0-10 numeric rating scale (NRS)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 weeks

Awards & highlights

Study Summary

This trial will compare the effects of real acupuncture, placebo acupuncture, and usual care on symptoms of nerve damage from chemotherapy.

Who is the study for?

This trial is for adults over 18 who have survived solid tumors with no current disease and suffer from moderate to severe nerve damage symptoms after chemotherapy. Participants should not have had any changes in their anti-neuropathy medication for three months and must speak English. Those with pacemakers or recent acupuncture treatments are excluded.Check my eligibility

What is being tested?

The study aims to assess the effectiveness of real acupuncture versus placebo (sham) acupuncture or usual care in managing symptoms like numbness, tingling, or pain caused by nerve damage from chemotherapy.See study design

What are the potential side effects?

Acupuncture may cause minor side effects such as bruising, bleeding at the needle sites, dizziness, fainting, or worsening of symptoms. The sham procedure might also lead to similar discomforts due to needle insertion.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I had cancer, but currently show no signs of the disease.

Select...

I experience significant numbness, tingling, or pain in my hands or feet.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

change in the proportion of patients with a CIPN severity

Side effects data

From 2013 Phase 1 & 2 trial • 104 Patients • NCT01305811

Serious unexpected

Pain on needling

100%

80%

60%

40%

20%

Study treatment Arm

Bi-Weekly Acupuncture

Wait List

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Placebo Group

Group I: Acupuncture Treatment GroupExperimental Treatment2 Interventions

Ten acupuncture treatments over the course of eight weeks, with twice weekly acupuncture treatments for the first two weeks, and then weekly treatment thereafter.

Group II: Usual Care GroupActive Control2 Interventions

Twelve weeks of usual care.

Group III: Sham Acupuncture Treatment GroupPlacebo Group2 Interventions

Ten sham acupuncture treatments over the course of eight weeks, with twice weekly sham acupuncture treatments for the first two weeks, and then weekly sham acupuncture treatment thereafter.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Acupuncture

2011

Completed Phase 3

~1240

questionnaires

2008

Completed Phase 2

~3450

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor

1,933 Previous Clinical Trials

585,545 Total Patients Enrolled

2 Trials studying Peripheral Neuropathy

79 Patients Enrolled for Peripheral Neuropathy

Ting Bao, MD, DABMA, MSPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

3 Previous Clinical Trials

546 Total Patients Enrolled

1 Trials studying Peripheral Neuropathy

28 Patients Enrolled for Peripheral Neuropathy

Media Library

Acupuncture Clinical Trial Eligibility Overview. Trial Name: NCT03183037 — N/A

Peripheral Neuropathy Research Study Groups: Sham Acupuncture Treatment Group, Usual Care Group, Acupuncture Treatment Group

Peripheral Neuropathy Clinical Trial 2023: Acupuncture Highlights & Side Effects. Trial Name: NCT03183037 — N/A

Acupuncture 2023 Treatment Timeline for Medical Study. Trial Name: NCT03183037 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there any additional capacity for participants in this research endeavor?

"According to clinicaltrials.gov, this trial is not currently seeking candidates. Initially posted on June 7th 2017 and updated more recently on July 18th 2022, the current search for patients has been suspended; however, there are 161 other trials searching for participants at present."

Answered by AI